Established in the year 2001 by Mr. Dhirajlal Kotadia, Sahajanand Medical Technologies Ltd is a manufacturer of medical devices in the classes of III and C/D, specializing in vascular and structural heart intervention devices. It was the world's first company to get the CE approval for DES having biodegradable polymer called Infinnium. Product Portfolio of Sahajanand includes three major categories: Vascular Intervention (VI): This includes coronary stents and balloons. Structural Heart (SH): This category includes advanced technology products such as Transcatheter Aortic Valve Implantation (TAVI) and Occluders. Other Products: These include renal stents, peripheral Drug-Coated Balloons (DCBs), and trading products.\nnResearch and development activities of the company are carried out in two centers located in India and Thailand. The staff of R&D consists of 102 people including biomedical engineers and specialists in clinical research. Sahajanand has a strong intellectual property portfolio: 102 granted patents, 71 patent applications and five design registrations in India. As of March 31, 2025, there were 1,458 full-time employees, 24 consultants and 818 contract-based employees in Sahajanand Medical Technologies.